Emma V Barker

Summary

Country: UK

Publications

  1. ncbi request reprint An ex vivo model for reperfusion of laryngotracheal grafts
    Emma Barker
    Division of Surgery, Department of Clinical Medicine, University of Bristol, Bristol, UK
    Laryngoscope 115:699-702. 2005
  2. pmc The larynx as an immunological organ: immunological architecture in the pig as a large animal model
    E Barker
    Clinical Science at North Bristol, University of Bristol, Southmead Hospital, Bristol, UK
    Clin Exp Immunol 143:6-14. 2006
  3. pmc Early immunological changes associated with laryngeal transplantation in a major histocompatibility complex-matched pig model
    E Barker
    Laryngeal Research Group, Faculty of Medicine and Dentistry, University of Bristol, Bristol, UK
    Clin Exp Immunol 146:503-8. 2006
  4. pmc From grunts to words: experiments in laryngeal transplantation
    Emma V Barker
    Department of Otorhinolaryngology, Wessex Deanery, Southampton, UK
    Ann R Coll Surg Engl 89:197-202. 2007
  5. doi request reprint Survey of prophylactic antibiotic use amongst UK cochlear implant surgeons
    Emma Barker
    South of England Cochlear Implant Centre, Institute of Sound and Vibration Research, University of Southampton, SO17 1BJ, UK
    Cochlear Implants Int 9:82-9. 2008
  6. doi request reprint The utility of microvascular anastomotic devices in head and neck reconstruction
    Emma V Barker
    Department of Otolaryngology Surgical Oncology, Princess Margaret Hospital, Canada
    Curr Opin Otolaryngol Head Neck Surg 16:331-4. 2008
  7. pmc microRNA evaluation of unknown primary lesions in the head and neck
    Emma V Barker
    Department of Applied Molecular Oncology, Princess Margaret Hospital, Ontario Cancer Institute and University Health Network, Toronto, Ontario M5G 2M9, Canada
    Mol Cancer 8:127. 2009

Detail Information

Publications7

  1. ncbi request reprint An ex vivo model for reperfusion of laryngotracheal grafts
    Emma Barker
    Division of Surgery, Department of Clinical Medicine, University of Bristol, Bristol, UK
    Laryngoscope 115:699-702. 2005
    ..To describe the development of an ex vivo model to facilitate the study of ischemia-reperfusion injury in laryngotracheal grafts taken from Minnesota minipigs...
  2. pmc The larynx as an immunological organ: immunological architecture in the pig as a large animal model
    E Barker
    Clinical Science at North Bristol, University of Bristol, Southmead Hospital, Bristol, UK
    Clin Exp Immunol 143:6-14. 2006
    ..The presence of such an immunological structure suggests that the larynx may have important functions in respiratory immunology and that it may trigger strong alloresponses after laryngeal transplantation...
  3. pmc Early immunological changes associated with laryngeal transplantation in a major histocompatibility complex-matched pig model
    E Barker
    Laryngeal Research Group, Faculty of Medicine and Dentistry, University of Bristol, Bristol, UK
    Clin Exp Immunol 146:503-8. 2006
    ..Therefore, the significance of IRI in exacerbating loss of function or rejection of a laryngeal allograft is open to question. Longer-term studies are required...
  4. pmc From grunts to words: experiments in laryngeal transplantation
    Emma V Barker
    Department of Otorhinolaryngology, Wessex Deanery, Southampton, UK
    Ann R Coll Surg Engl 89:197-202. 2007
    ..The presence of immunologically active cells within non-transplanted NIH-minipigs was investigated and an in vivo laryngeal transplant model was developed...
  5. doi request reprint Survey of prophylactic antibiotic use amongst UK cochlear implant surgeons
    Emma Barker
    South of England Cochlear Implant Centre, Institute of Sound and Vibration Research, University of Southampton, SO17 1BJ, UK
    Cochlear Implants Int 9:82-9. 2008
    ..The type of antibiotic and duration vary significantly between centres. Interestingly, however, the regimes followed by most practices do not adhere to surgical principles of antibiotic prophylaxis...
  6. doi request reprint The utility of microvascular anastomotic devices in head and neck reconstruction
    Emma V Barker
    Department of Otolaryngology Surgical Oncology, Princess Margaret Hospital, Canada
    Curr Opin Otolaryngol Head Neck Surg 16:331-4. 2008
    ..Although more acceptable in venous anastomosis, their use in arterial anastomosis remains limited. We review the literature to evaluate the evidence both for and against their use, in both venous and arterial anastomoses...
  7. pmc microRNA evaluation of unknown primary lesions in the head and neck
    Emma V Barker
    Department of Applied Molecular Oncology, Princess Margaret Hospital, Ontario Cancer Institute and University Health Network, Toronto, Ontario M5G 2M9, Canada
    Mol Cancer 8:127. 2009
    ..This may be clinically relevant to predict the primary site of origin of metastatic disease, when the primary site remains obscure...